"LFA Tests: High Sensitivity, Low Cost, and Ease of Use"
Several industries, including healthcare, animal health, food and feed testing, environmental testing, and plant disease testing, have embraced lateral flow assay techniques. The cross applications of lateral flow assays include food testing and drug misuse testing in addition to infectious illness testing and pregnancy testing. Most significantly, LFA tests are frequently used because they are simple to use, which reduces the need for frequent hospital visits. As a result, LFA technologies have a significant market share for assessing seasonal and outbreak indications like dengue, malaria, etc. The veterinary industry has also quickly accepted lateral flow assay testing, which is boosting the market's overall growth.
Due to the low cost, easy accessibility, and higher sensitivity of LFA tests for infectious disease testing, lower-middle income nations are expected to have substantial expansion in terms of adoption.
The development of medications and therapies for rare diseases including malaria, salmonella, and others will receive more attention in research and development, which will further expand the market for lateral flow test products.
The availability of reimbursement rules, funding initiatives, and significant cooperative efforts among top pharmaceutical producers will all support market expansion.
To speed up the marketing and distribution of its AffiDX COVID-19 antigen lateral flow test in the United Kingdom and the European Economic Area, for instance, Avacta Group and Calibre Scientific struck a non-exclusive distribution agreement in 2021. (EEA).
Why is Lateral Flow Assay Demand Negatively Affected?
"High Market Competition Produces Sub-Standard Products"
LFAs have trouble reproducing their findings. The outcomes of LFA tests performed on the same subject at various intervals could be very different. The difficulty of simultaneously analysing several markers (multiplexing) is another issue with LFA. The precision of the results can be affected by inaccurate sample volume.
Pricing pressure is a result of the poor value and huge volume of LFA kits combined with the declining cost of manufacture. Due to vendor competition centred on volume and price, there are low-quality products available on the market.
LFAs are primarily qualitative tests that look for disease presence. They can, at most, offer results that are semi-quantitative and dependent on colour. Since lateral flow tests do not give quantifiable detection, they are only suitable for primary screening and cannot be used to gauge the severity of a problem that is being diagnosed.
Need More Report https://www.factmr.com/report/lateral-flow-assays-market
Contact Us:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com
Website: https://www.factmr.com
